Henry Kahwaty
Henry Kahwaty’s areas of expertise include microeconomics, industrial organization, antitrust economics, and econometrics.
He has completed numerous antitrust reviews of mergers and horizontal and vertical contractual arrangements. He has also completed studies of monopolization and abuse of dominance in the context of government investigations and private litigation. His merger work includes studies of mergers in metals, solid waste, industrial products, computer hardware and software, defense electronics, pharmaceuticals, electricity, consumer goods, and telecommunications.
In addition, Dr. Kahwaty has analyzed competition issues in the mining, luxury goods, banking, and hardware emulation industries. He has completed studies of vertical restraints and vertical integration, and the impact of such vertical relationships on competition. His work also includes the study of price fixing allegations, class certification, and antitrust damages.
Dr. Kahwaty also has completed analyses of intellectual property damages and the economic impact of changes in government policy. Dr. Kahwaty’s policy work includes the analysis of issues in healthcare, including the costs associated with changes in Medicare, Medicaid, and the availability of generic drugs and biologic medicines. He has also worked on small business issues.
Dr. Kahwaty has presented analyses to the Antitrust Division of the US Department of Justice (DOJ), Federal Trade Commission (FTC), Directorate-General for Competition of the European Commission (EC), Federal Energy Regulatory Commission, Centers for Medicare & Medicaid Services, Congressional Budget Office, Congressional Committee Staff, Medicare Payment Advisory Commission, and Small Business Administration.
In addition, Dr. Kahwaty has analyzed competition issues in the mining, luxury goods, banking, and hardware emulation industries. He has completed studies of vertical restraints and vertical integration, and the impact of such vertical relationships on competition. His work also includes the study of price fixing allegations, class certification, and antitrust damages.
Dr. Kahwaty also has completed analyses of intellectual property damages and the economic impact of changes in government policy. Dr. Kahwaty’s policy work includes the analysis of issues in healthcare, including the costs associated with changes in Medicare, Medicaid, and the availability of generic drugs and biologic medicines. He has also worked on small business issues.
Dr. Kahwaty has presented analyses to the Antitrust Division of the US Department of Justice (DOJ), Federal Trade Commission (FTC), Directorate-General for Competition of the European Commission (EC), Federal Energy Regulatory Commission, Centers for Medicare & Medicaid Services, Congressional Budget Office, Congressional Committee Staff, Medicare Payment Advisory Commission, and Small Business Administration.